Report cover image

Global Nucleic Acid Amplification Testing Market Size study, by Type (Polymerase Chain Reaction (PCR) Tests, Isothermal Nucleic Acid Amplification Technology (INAAT) Tests, Ligase Chain Reaction (LCR) Tests), by Application (Infectious Disease Testing, On

Publisher Bizwit Research & Consulting
Published Aug 10, 2024
Length 285 Pages
SKU # BIZW19075430

Description

Global Nucleic Acid Amplification Testing Market Size study, by Type (Polymerase Chain Reaction (PCR) Tests, Isothermal Nucleic Acid Amplification Technology (INAAT) Tests, Ligase Chain Reaction (LCR) Tests), by Application (Infectious Disease Testing, Oncology Testing, Genetic & Mitochondrial Disease Testing, Others), by End-use (Hospitals, Central And Reference Laboratories, Others) and Regional Forecasts 2022-2032


The Global Nucleic Acid Amplification Testing Market is valued at approximately USD 8.19 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 12.2% over the forecast period 2024-2032. Nucleic Acid Amplification Testing (NAAT) is a molecular technique used to detect and amplify specific nucleic acid sequences, such as DNA or RNA, from pathogens or genetic material. This method includes PCR (Polymerase Chain Reaction), RT-PCR (Reverse Transcription PCR), and LAMP (Loop-Mediated Isothermal Amplification). NAAT is highly sensitive and specific, making it valuable for diagnosing infectious diseases like COVID-19, tuberculosis, and HIV. It is also used in genetic testing, cancer detection, and forensic science. NAAT enables early and accurate detection of diseases, guiding appropriate treatment and management strategies.

The market's growth is fueled by a surge in demand for advanced rapid diagnostics and rising R&D investments in developing novel biotechnological diagnostic techniques. The high global prevalence of infectious diseases and the need for highly efficient testing alternatives to successfully manage disease outbreaks have propelled the demand for various nucleic acid amplification testing technologies. COVID-19, in particular, has significantly increased the demand for rapid and accurate testing methods to detect the SARS-CoV-2 virus. Key market players have responded by developing new product offerings, such as isothermal nucleic acid amplification technology-based tests, to meet the high demand for rapid and point-of-care testing.

The major factors driving the NAAT market include the rising prevalence of infectious diseases, increasing demand for advanced diagnostic measures, and growing investment in developing new biotechnological diagnostic techniques. However, a lack of skilled professionals and the higher costs associated with these tests may restrain the market's growth. Nonetheless, the global increase in healthcare spending and continuous advancements in diagnostic technology provide significant growth opportunities for the NAAT market.

North America dominated the market in 2023, accounting for the largest revenue share due to the high prevalence of chronic diseases and the presence of an established research and healthcare infrastructure. The demand for nucleic acid amplification tests in the region is driven by the increasing focus on point-of-care diagnostic methods and extensive disease prevention measures. In contrast, the Asia Pacific region is expected to grow at the fastest CAGR during the forecast period, driven by its large population and rising focus on healthcare systems. The high incidence of emerging infectious diseases such as Japanese encephalitis, Hendra, and Nipah virus infections can strengthen the market prospects for nucleic acid amplification testing in the region.

Major market players included in this report are:

F. Hoffmann-La Roche Ltd

Becton, Dickinson and Company

Danaher Corporation

Abbott Laboratories

Illumina, Inc.

Siemens Healthineers

bioMérieux SA

Novartis AG

Bio-Rad Laboratories, Inc.

Seegene Inc.

The detailed segments and sub-segment of the market are explained below:

By Type:
• Polymerase Chain Reaction (PCR) Tests
• Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
• Ligase Chain Reaction (LCR) Tests

By Application:
• Infectious Disease Testing
• Oncology Testing
• Genetic & Mitochondrial Disease Testing
• Others

By End-use:
• Hospitals
• Central And Reference Laboratories
• Others

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico
• RoLA

Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Table of Contents

285 Pages
Chapter 1. Global Nucleic Acid Amplification Testing Market Executive Summary
1.1. Global Nucleic Acid Amplification Testing Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Type
1.3.2. By Application
1.3.3. By End-use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Nucleic Acid Amplification Testing Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Nucleic Acid Amplification Testing Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Prevalence of Infectious Diseases
3.1.2. Rising Investment in Biotechnological Diagnostics
3.1.3. Technological Advancements in Diagnostic Methods
3.2. Market Challenges
3.2.1. Lack of Skilled Professionals
3.2.2. High Costs Associated with NAAT
3.3. Market Opportunities
3.3.1. Expansion in Emerging Markets
3.3.2. Growth in Point-of-Care Diagnostics
3.3.3. Increasing R&D Investments
Chapter 4. Global Nucleic Acid Amplification Testing Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Nucleic Acid Amplification Testing Market Size & Forecasts by Type 2022-2032
5.1. Segment Dashboard
5.2. Global Nucleic Acid Amplification Testing Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Polymerase Chain Reaction (PCR) Tests
5.2.2. Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
5.2.3. Ligase Chain Reaction (LCR) Tests
Chapter 6. Global Nucleic Acid Amplification Testing Market Size & Forecasts by Application 2022-2032
6.1. Segment Dashboard
6.2. Global Nucleic Acid Amplification Testing Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Infectious Disease Testing
6.2.2. Oncology Testing
6.2.3. Genetic & Mitochondrial Disease Testing
6.2.4. Others
Chapter 7. Global Nucleic Acid Amplification Testing Market Size & Forecasts by End-use 2022-2032
7.1. Segment Dashboard
7.2. Global Nucleic Acid Amplification Testing Market: End-use Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Hospitals
7.2.2. Central And Reference Laboratories
7.2.3. Others
Chapter 8. Global Nucleic Acid Amplification Testing Market Size & Forecasts by Region 2022-2032
8.1. North America Nucleic Acid Amplification Testing Market
8.1.1. U.S. Nucleic Acid Amplification Testing Market
8.1.1.1. Type breakdown size & forecasts, 2022-2032
8.1.1.2. Application breakdown size & forecasts, 2022-2032
8.1.1.3. End-use breakdown size & forecasts, 2022-2032
8.1.2. Canada Nucleic Acid Amplification Testing Market
8.2. Europe Nucleic Acid Amplification Testing Market
8.2.1. U.K. Nucleic Acid Amplification Testing Market
8.2.2. Germany Nucleic Acid Amplification Testing Market
8.2.3. France Nucleic Acid Amplification Testing Market
8.2.4. Spain Nucleic Acid Amplification Testing Market
8.2.5. Italy Nucleic Acid Amplification Testing Market
8.2.6. Rest of Europe Nucleic Acid Amplification Testing Market
8.3. Asia-Pacific Nucleic Acid Amplification Testing Market
8.3.1. China Nucleic Acid Amplification Testing Market
8.3.2. India Nucleic Acid Amplification Testing Market
8.3.3. Japan Nucleic Acid Amplification Testing Market
8.3.4. Australia Nucleic Acid Amplification Testing Market
8.3.5. South Korea Nucleic Acid Amplification Testing Market
8.3.6. Rest of Asia Pacific Nucleic Acid Amplification Testing Market
8.4. Latin America Nucleic Acid Amplification Testing Market
8.4.1. Brazil Nucleic Acid Amplification Testing Market
8.4.2. Mexico Nucleic Acid Amplification Testing Market
8.4.3. Rest of Latin America Nucleic Acid Amplification Testing Market
8.5. Middle East & Africa Nucleic Acid Amplification Testing Market
8.5.1. Saudi Arabia Nucleic Acid Amplification Testing Market
8.5.2. South Africa Nucleic Acid Amplification Testing Market
8.5.3. Rest of Middle East & Africa Nucleic Acid Amplification Testing Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. F. Hoffmann-La Roche Ltd
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Becton, Dickinson and Company
9.3.3. Danaher Corporation
9.3.4. Abbott Laboratories
9.3.5. Illumina, Inc.
9.3.6. Siemens Healthineers
9.3.7. bioMérieux SA
9.3.8. Novartis AG
9.3.9. Bio-Rad Laboratories, Inc.
9.3.10. Seegene Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
List of Tables
TABLE 1. Global Nucleic Acid Amplification Testing market, report scope
TABLE 2. Global Nucleic Acid Amplification Testing market estimates & forecasts by Region 2022-2032 (USD Billion)
TABLE 3. Global Nucleic Acid Amplification Testing market estimates & forecasts by Type 2022-2032 (USD Billion)
TABLE 4. Global Nucleic Acid Amplification Testing market estimates & forecasts by Application 2022-2032 (USD Billion)
TABLE 5. Global Nucleic Acid Amplification Testing market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 6. Global Nucleic Acid Amplification Testing market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 7. Global Nucleic Acid Amplification Testing market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 8. Global Nucleic Acid Amplification Testing market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 9. Global Nucleic Acid Amplification Testing market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 10. Global Nucleic Acid Amplification Testing market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 11. Global Nucleic Acid Amplification Testing market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 12. Global Nucleic Acid Amplification Testing market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 13. Global Nucleic Acid Amplification Testing market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 14. Global Nucleic Acid Amplification Testing market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 15. U.S. Nucleic Acid Amplification Testing market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 16. U.S. Nucleic Acid Amplification Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 17. U.S. Nucleic Acid Amplification Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 18. Canada Nucleic Acid Amplification Testing market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 19. Canada Nucleic Acid Amplification Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 20. Canada Nucleic Acid Amplification Testing market estimates & forecasts by segment 2022-2032 (USD Billion)
This list is not complete, final report does contain more than 100 tables. The list may be updated in the final deliverable.
List of Figures
FIGURE 1. Global Nucleic Acid Amplification Testing market, research methodology
FIGURE 2. Global Nucleic Acid Amplification Testing market, market estimation techniques
FIGURE 3. Global market size estimates & forecast methods.
FIGURE 4. Global Nucleic Acid Amplification Testing market, key trends 2023
FIGURE 5. Global Nucleic Acid Amplification Testing market, growth prospects 2022-2032
FIGURE 6. Global Nucleic Acid Amplification Testing market, porters 5 force model
FIGURE 7. Global Nucleic Acid Amplification Testing market, PESTEL analysis
FIGURE 8. Global Nucleic Acid Amplification Testing market, value chain analysis
FIGURE 9. Global Nucleic Acid Amplification Testing market by segment, 2022 & 2032 (USD Billion)
FIGURE 10. Global Nucleic Acid Amplification Testing market by segment, 2022 & 2032 (USD Billion)
FIGURE 11. Global Nucleic Acid Amplification Testing market by segment, 2022 & 2032 (USD Billion)
FIGURE 12. Global Nucleic Acid Amplification Testing market by segment, 2022 & 2032 (USD Billion)
FIGURE 13. Global Nucleic Acid Amplification Testing market by segment, 2022 & 2032 (USD Billion)
FIGURE 14. Global Nucleic Acid Amplification Testing market, regional snapshot 2022 & 2032
FIGURE 15. North America Nucleic Acid Amplification Testing market 2022 & 2032 (USD Billion)
FIGURE 16. Europe Nucleic Acid Amplification Testing market 2022 & 2032 (USD Billion)
FIGURE 17. Asia pacific Nucleic Acid Amplification Testing market 2022 & 2032 (USD Billion)
FIGURE 18. Latin America Nucleic Acid Amplification Testing market 2022 & 2032 (USD Billion)
FIGURE 19. Middle East & Africa Nucleic Acid Amplification Testing market 2022 & 2032 (USD Billion)
FIGURE 20. Global Nucleic Acid Amplification Testing market, company market share analysis (2023)
This list is not complete, final report does contain more than 50 figures. The list may be updated in the final deliverable.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us